Arnoud Huisman is an executive leader with 30 years experience and expertise in a wide variety of life sciences area’s. Several leadership roles in commercial, strategy and scientific management, always at the edge of creating Value out of Science. As Chief Executive Officer (CEO) and chairman of the board within Oncode Accelerator, Arnoud will focus on the acquisition of demonstrator projects and co-funding.

Oncode Accelerator

Oncode Accelerator is a public-private program which aims to innovate and accelerate the development of new cancer therapies by placing cancer patients at the core of preclinical therapy development.

We realize this through the power of three innovation platforms: Patient Cohorts, Organoids and Artificial Intelligence.

Over 30 partners leverage the full potential of the Dutch innovation ecosystem by building development pipelines for four of the most common types of cancer therapies: Small Molecules, Biologics, Cell and Gene Therapies, and Therapeutic Vaccines.

Our world-class toolbox of state-of-the-art technologies will result in more effective, personalized cancer therapies. This will bring us closer to our overarching vision: outsmarting cancer, impacting lives.

At Innovation for Health, we will announce the opening of our first call and are actively looking for partners in biotech and pharma that can bring lead candidates into our pre-clinical program.